Literature DB >> 11809258

A novel mechanism for thalassaemia intermedia.

C Badens, M G Mattei, A M Imbert, C Lapouméroulie, N Martini, G Michel, D Lena-Russo.   

Abstract

Thalassaemia intermedia is a moderate form of thalassaemia resulting from various genetic defects. We report an undescribed mechanism leading to this condition: a somatic deletion of the beta-globin gene in the haemopoietic lineage of a heterozygous beta-thalassaemic patient. We did molecular studies and haemoglobin analysis of the patient and his parents. We found that the deletion gives rise to a mosaic of cells with either one or no functional beta-globin gene and it extends to a region of frequent loss of heterozygosity called LOH11A, which is located close to the beta-globin locus. Thus, loss of heterozygosity can be a cause of non-malignant genetic disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809258     DOI: 10.1016/s0140-6736(02)07338-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  HBB loss of heterozygosity in the hemopoietic lineage gives rise to an unusual sickle-cell trait phenotype.

Authors:  Philippe Joly; Caroline Schluth-Bolard; Philippe Lacan; Claire Barro; Serge Pissard; Audrey Labalme; Damien Sanlaville; Catherine Badens
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 2.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

4.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

5.  Mosaic segmental uniparental isodisomy and progressive clonal selection: a common mechanism of late onset β-thalassemia major.

Authors:  Cornelis L Harteveld; Chiara Refaldi; Antonino Giambona; Claudia A L Ruivenkamp; Mariëtte J V Hoffer; Jeroen Pijpe; Peter De Knijff; Caterina Borgna-Pignatti; Aurelio Maggio; Maria D Cappellini; Piero C Giordano
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

6.  Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia.

Authors:  Maria Carla Sollaino; Maria Elisabetta Paglietti; Lucia Perseu; Nicolina Giagu; Daniela Loi; Renzo Galanello
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 7.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 8.  Parents of children with autosomal recessive diseases are not always carriers of the respective mutant alleles.

Authors:  Joel Zlotogora
Journal:  Hum Genet       Date:  2004-03-16       Impact factor: 4.132

Review 9.  The hemoglobinopathies, molecular disease mechanisms and diagnostics.

Authors:  Cornelis L Harteveld; Ahlem Achour; Sandra J G Arkesteijn; Jeanet Ter Huurne; Maaike Verschuren; Sharda Bhagwandien-Bisoen; Rianne Schaap; Linda Vijfhuizen; Hakima El Idrissi; Tamara T Koopmann
Journal:  Int J Lab Hematol       Date:  2022-09       Impact factor: 3.450

10.  β Thalassemia major due to acquired uniparental disomy in a previously healthy adolescent.

Authors:  Celeste Bento; Tabita M Maia; Jelena D Milosevic; Isabel M Carreira; Robert Kralovics; M Leticia Ribeiro
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.